title: Medication-related osteonecrosis of the jaw associated with aflibercept.
authors.affiliation: Department of Oral & Maxillofacial Surgery, Royal Free London NHS Foundation Trust, London, UK. Electronic address: Parisa.zarringhalam@gmail.com.
authors.forename: P
authors.initials: P
authors.lastname: Zarringhalam
authors.affiliation: Department of Oral & Maxillofacial Surgery, Royal Free London NHS Foundation Trust, London, UK. Electronic address: ebrizman@nhs.net.
authors.forename: E
authors.initials: E
authors.lastname: Brizman
authors.affiliation: Department of Oral & Maxillofacial Surgery, Royal Free London NHS Foundation Trust, London, UK. Electronic address: k.shakib@nhs.net.
authors.forename: K
authors.initials: K
authors.lastname: Shakib
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy; D006801:Humans; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011862:Radiography, Panoramic; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor
keywords: Aflibercept; Chemotherapy; Medication Related; Osteonecrosis